Skip to main content
← All topics Watch the film · 1:46 Measured in the Enginerds corpus

New England Journal of Medicine

New England Journal of Medicine appears in 33 analyzed articles across the measured technology press. Recent coverage is steady, counting every mention over recent months. This page shows the public snapshot: movement, coverage mix, recent sources, and what drove the latest change.

Compass measures press coverage, not New England Journal of Medicine's product quality, business performance, or market value.

What's happening with New England Journal of Medicine?

Counting every mention, coverage of New England Journal of Medicine is steady — it appears in 33 analyzed articles across the technology press.

Coverage Mix
New England Journal of Medicineorganization
13 classified coverage items · 13 measured articles · Jul 2025 – Sep 2026

What New England Journal of Medicine coverage is made of over time: story type, claim stage as reported, and press framing. This measures the coverage, not the product.

Across 13 classified coverage items, one item is 7.7 percentage points — read the shares below as the shape of a small sample, not as figures precise to the point.

Story type and claim stage are shares of the 13 classified coverage items in this window.

VolumeClassified items rose over this window ↑
Make-upMostly Launch · 61% by story type
Framing Critical 8%, otherwise neutral
How to read this

The stream below stacks each month's coverage by the lens you choose: Tone (how the press frames the story — promotional, skeptical, critical, or neutral), Story type (launches, funding, lawsuits, partnerships…), or Stage — how far the reported claim has gone: speculation → announcement → launch → results.

Taller bands mean more coverage that month; the dots beneath mark notable non‑neutral events. Every signal is sourced and dated.

Coverage is 61% announcement-stage (by claim stage) and mostly neutral — but critical framing runs at 8%, much of it on the Launch · New England Journal of Medicine storyline.
Corporate coverage — the stage ladder reflects how far this company's announced moves had progressed, not a verdict on the company.
Coverage items
13
Lead specific story type
Launch 61%
Notable framing
Critical 8% ↓
otherwise mostly neutral (92%)
Trend lens
y‑axis: items with readable framing / month
CriticalNeutral
nowpeak · 301235Jul '25Sep '25Dec '25Feb '26Apr '26Jul '26Sep '26
Click any month to see what drove it
How this is counted — why the article numbers differ

33 articles mention New England Journal of Medicine across the corpus. The coverage make-up above is measured on the 13 of them that were read into dated, classified coverage items — and one article can produce more than one item, because story type, claim stage and framing are read separately.

Want the full workspace? A free account opens the full instrument — Coverage, Connections, and Compare, on New England Journal of Medicine or any other topic. Free reads each tab over the last 30 days, and a full sourced report on any topic is $19, one-time; Pro and Plus are the same instrument at full capacity — 15 months of history, reports included, watches, and alerts. The full-record chart on this page stays free to browse either way.
What drove the latest coverage · latest month with open events: Sep 2026
  • launch A case report about neuroschistosomiasis was published in the New England Journal of Medicine.
  • launch Late-stage clinical trial results for retatrutide were published in the New England Journal of Medicine.
The busiest measured month (May 2026) sits before the open event window — these are the strongest cited stories from the latest open month. They explain that month's cluster; they do not prove causation. Open May 2026's events in the workspace →
What Compass measures here
Recent direction→ mixed / steady
Articles33
Persistence (current)3 mo
Persistence (longest)8 mo

As of 8 Oct 2026 · corpus coverage 94% · 358,204 articles. Correlational & coverage-limited.

Keep watching New England Journal of Medicine with Pro
  1. ✓
    This snapshotDirection, footprint & coverage make-up — free, no account, always
  2. 🔒
    Full history & coverage trailMonth-by-month make-up & every cited source
  3. 🔒
    ConnectionsThe topics it's most often covered alongside
  4. 🔒
    Compare & exportBenchmark vs. other topics; export the source pack
  5. 🔒
    Watchlist & alertsGet pinged when the make-up or direction shifts
Keep watching New England Journal of Medicine with Pro — from $59/mo → What is Compass? →
Source: Enginerds Compass — measurements over a longitudinal technology corpus. Not investment advice. © Enginerds. Counted over the published source panel.